FEV and ProLogium develop high-performance vehicle battery
more
Stories from Aachen
- Language:
- Media:
- Period:
- Period:Total
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
moreFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
moreFraunhofer-Institut für Produktionstechnologie IPT
2Deep learning for real-time quality control: Aachen-based Fraunhofer Institutes improve defect detection in weld seams
moreGoogle Recognizes P3 as Accredited Android™ Automotive 3PL Vendor for AAOS Compliance/xTS
moreGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
moreFraunhofer-Institut für Produktionstechnologie IPT
Life cycle assessment for energy-efficient and climate-friendly optics production
moreGrünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...
more- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more Fraunhofer-Institut für Produktionstechnologie IPT
5G Industry Campus Europe in Aachen expanded with Cloud RAN
more- 3
LAMILUX Continuous Rooflight B: Four new certifications
One documentmore Fraunhofer-Institut für Produktionstechnologie IPT
Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks
more- 2
agineo strengthens its international presence with new branches in Europe
more Fraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer study report describes AI use cases and sustainable energy concepts
moreFraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
moreBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
moreBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
moreFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer IPT conducts research into automated series production of optics with new glass press
moreGrünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
moreFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer study report on cybersecurity, digital twins and sustainability in production
more- 4
Steigenberger Hotels & Resorts brand coming to Bielefeld
One documentmore Empowering the Future of Pain Relief Research: Recipients of the 2023 EFIC-Grünenthal Grant Announced
Brussels/Aachen (ots) - - Three promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2023. - The E-G-G funds innovative research projects to advance understanding of pain and improve the lives of people suffering from pain. The European Pain Federation EFIC® and the ...
moreGrünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee
Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...
moreFraunhofer-Institut für Produktionstechnologie IPT
Joint expertise from industry and research: New regulations standardize optical coherence tomography
moreGrünenthal and King’s College London collaborate to develop human induced pluripotent stem cell-based microfluidic cultures for pain research
Aachen, Germany and London, England (ots) - - Dr Ramin Raouf from King's College London and Grünenthal strive to develop reliable microfluidic culture models relevant for pain research based on human induced pluripotent stem cell-derived neurons - Grünenthal has expertise in developing human induced pluripotent ...
moreFraunhofer-Institut für Produktionstechnologie IPT
Go-ahead for 6G in industry: EU funds technology development with more than 13 million euros
moreFraunhofer-Institut für Produktionstechnologie IPT
Fraunhofer IPT manufactures super-lightweight frame for experiments in outer space
moreJanneke van der Kamp starts as new Chief Commercial Officer at Grünenthal
moreHDI TH!NX makes battery reliability insurable on the basis of ACCURE battery analytics
moreBVG Trials ACCURE’s Battery Safety Monitoring System on Electric Buses
more
12Next